MCH ADVISORY RESEARCHMain site ↗
Sector

Real Estate

56 companies under coverage across 14 industries.

Industries

Browse by industry


Coverage

Real Estate companies


Equity Research

Vornado Realty Trust (VNO)

BUY. 12-month probability-weighted target $44 (+24% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

VNOEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +19.4%
Equity Research

Host Hotels & Resorts Inc (HST)

BUY. 12-month probability-weighted target $27 (+21% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

HSTEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +17.1%
Equity Research

Cousins Properties Incorporated (CUZ)

HOLD. 12-month probability-weighted target $33 (+15% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CUZEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +12.5%
Equity Research

Agree Realty Corporation (ADC)

HOLD. 12-month probability-weighted target $82 (+13% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

ADCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +9.6%
Equity Research

STAG Industrial Inc (STAG)

HOLD. 12-month probability-weighted target $43 (+13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

STAGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +9.5%
Equity Research

Brixmor Property (BRX)

HOLD. 12-month probability-weighted target $33 (+13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

BRXEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +9.2%
Equity Research

UDR Inc (UDR)

HOLD. 12-month probability-weighted target $40 (+12% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

UDREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +8.9%
Equity Research

Weyerhaeuser Company (WY)

HOLD. 12-month probability-weighted target $25 (+9% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

WYEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +7.3%
Equity Research

Healthcare Realty Trust Incorporated (HR)

HOLD. 12-month probability-weighted target $21 (+11% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

HREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +7.3%
Equity Research

Kite Realty Group Trust (KRG)

HOLD. 12-month probability-weighted target $30 (+15% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

KRGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +6.7%
Equity Research

EastGroup Properties Inc (EGP)

HOLD. 12-month probability-weighted target $220 (+10% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

EGPEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +6.5%
Equity Research

Mid-America Apartment Communities Inc (MAA)

HOLD. 12-month probability-weighted target $141 (+10% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

MAAEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +6.3%
Equity Research

Gaming & Leisure Properties (GLPI)

HOLD. 12-month probability-weighted target $46 (+9% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

GLPIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +6.1%
Equity Research

Public Storage (PSA)

HOLD. 12-month probability-weighted target $330 (+9% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PSAEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +6.0%
Equity Research

First Industrial Realty Trust Inc (FR)

HOLD. 12-month probability-weighted target $68 (+10% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +5.8%
Equity Research

Kilroy Realty Corp (KRC)

HOLD. 12-month probability-weighted target $39 (+8% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

KRCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +5.6%
Equity Research

Essex Property Trust Inc (ESS)

HOLD. 12-month probability-weighted target $303 (+9% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

ESSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +5.4%
Equity Research

NNN REIT, Inc. (NNN)

HOLD. 12-month probability-weighted target $48 (+8% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

NNNEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +5.0%
Equity Research

Alexandria Real Estate Equities Inc (ARE)

HOLD. 12-month probability-weighted target $55 (+8% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

AREEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +4.8%
Equity Research

Regency Centers Corporation (REG)

HOLD. 12-month probability-weighted target $82 (+8% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

REGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +4.7%
Equity Research

W P Carey Inc (WPC)

HOLD. 12-month probability-weighted target $76 (+8% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

WPCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +4.7%
Equity Research

CareTrust REIT Inc. (CTRE)

HOLD. 12-month probability-weighted target $42 (+6% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

CTREEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +3.9%
Equity Research

Independence Realty Trust Inc (IRT)

HOLD. 12-month probability-weighted target $17 (+7% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

IRTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +3.8%
Equity Research

Federal Realty Investment Trust (FRT)

HOLD. 12-month probability-weighted target $123 (+5% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

FRTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +3.4%
Equity Research

Extra Space Storage Inc (EXR)

HOLD. 12-month probability-weighted target $148 (+6% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

EXREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +2.9%
Equity Research

Camden Property Trust (CPT)

HOLD. 12-month probability-weighted target $111 (+6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

CPTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +2.9%
Equity Research

EPR Properties (EPR)

HOLD. 12-month probability-weighted target $63 (+6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

EPREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +2.8%
Equity Research

Lamar Advertising Company (LAMR)

HOLD. 12-month probability-weighted target $158 (+5% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

LAMREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +2.7%
Equity Research

CoStar Group Inc (CSGP)

HOLD. 12-month probability-weighted target $30 (+0% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

CSGPEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +2.3%
Equity Research

Crown Castle (CCI)

HOLD. 12-month probability-weighted target $80 (+5% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

CCIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.9%
Equity Research

Realty Income Corporation (O)

HOLD. 12-month probability-weighted target $63 (+4% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

OEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.9%
Equity Research

Welltower Inc (WELL)

HOLD. 12-month probability-weighted target $243 (+3% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

WELLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.3%
Equity Research

Omega Healthcare Investors Inc (OHI)

HOLD. 12-month probability-weighted target $49 (+5% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

OHIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.2%
Equity Research

COPT Defense Properties (CDP)

HOLD. 12-month probability-weighted target $36 (+3% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CDPEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +0.5%
Equity Research

CubeSmart (CUBE)

HOLD. 12-month probability-weighted target $41 (+4% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

CUBEEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +0.5%
Equity Research

VICI Properties Inc (VICI)

HOLD. 12-month probability-weighted target $26 (+3% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

VICIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +0.3%
Equity Research

Equity Lifestyle Properties Inc (ELS)

HOLD. 12-month probability-weighted target $64 (+3% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

ELSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -0.3%
Equity Research

Invitation Homes Inc (INVH)

HOLD. 12-month probability-weighted target $29 (+2% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

INVHEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -0.4%
Equity Research

American Homes 4 Rent (AMH)

HOLD. 12-month probability-weighted target $33 (+3% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

AMHEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -0.6%
Equity Research

Prologis Inc (PLD)

HOLD. 12-month probability-weighted target $140 (+1% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

PLDEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -0.7%
Equity Research

Simon Property Group Inc (SPG)

HOLD. 12-month probability-weighted target $232 (+9% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

SPGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -0.9%
Equity Research

Digital Realty Trust Inc (DLR)

HOLD. 12-month probability-weighted target $196 (+3% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

DLREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -1.1%
Equity Research

BXP, Inc. (BXP)

HOLD. 12-month probability-weighted target $67 (+2% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

BXPEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -1.5%
Equity Research

Equinix Inc (EQIX)

HOLD. 12-month probability-weighted target $1054 (+1% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

EQIXEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -1.6%
Equity Research

Rayonier Inc (RYN)

HOLD. 12-month probability-weighted target $22 (+8% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

RYNEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -1.8%
Equity Research

Rexford Industrial Realty Inc (REXR)

HOLD. 12-month probability-weighted target $38 (+1% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

REXREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -2.2%
Equity Research

Ventas Inc (VTR)

HOLD. 12-month probability-weighted target $92 (+2% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

VTREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -2.3%
Equity Research

Healthpeak Properties Inc (DOC)

HOLD. 12-month probability-weighted target $21 (+1% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

DOCEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -2.5%
Equity Research

American Tower Corp (AMT)

HOLD. 12-month probability-weighted target $174 (-1% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

AMTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.1%
Equity Research

Park Hotels & Resorts Inc (PK)

HOLD. 12-month probability-weighted target $15 (-3% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

PKEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -7.5%
Equity Research

Sabra Healthcare REIT Inc (SBRA)

HOLD. 12-month probability-weighted target $20 (-6% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

SBRAEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -9.0%
Equity Research

SBA Communications Corp (SBAC)

HOLD. 12-month probability-weighted target $179 (-5% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

SBACEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -9.0%
Equity Research

CBRE Group Inc Class A (CBRE)

HOLD. 12-month probability-weighted target $133 (-6% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

CBREEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -16.9%
Equity Research

American Healthcare REIT, Inc. (AHR)

SELL. 12-month probability-weighted target $47 (-14% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AHREquity ResearchMonte Carlo
9 September 2026Rating: SELL · -17.3%
Equity Research

Iron Mountain Incorporated (IRM)

SELL. 12-month probability-weighted target $98 (-16% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

IRMEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -17.8%
Equity Research

Jones Lang LaSalle Incorporated (JLL)

HOLD. 12-month probability-weighted target $326 (-7% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

JLLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -17.9%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed